iLoF is a digital health company pioneering a breakthrough AI platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster.

Our breakthrough AI-powered platform collects and integrates massive amounts of optical signals that convert the biological sample into a rich phenotypic signature – overcoming the traditional limits of biochemical analysis and facilitating personalized and precision medicine applications. We analyze blood samples obtained from patients using cutting-edge optical lasers that excite relevant targets in the sample. We acquire an optical signal and process it using our proprietary AI pipeline, creating a unique digital molecular profile. We compare this fingerprint with our cloud-based finger library for potential matches, facilitating the development of personalized treatments. Our cloud-based library of optical fingerprints, powered by photonics and AI, provides non-invasive tracking, screening, and stratification for drug discovery, adapted to each clinical trial needs. Our blood-based screening test stratifies patients for clinical trials, removing heterogeneity due to underlying pathophysiology, disease stage, or degree of progression. We believe the possibilities for the iLoF Platform are endless. Keeping Alzheimer’s as a leading focus, we are building out our virtual fingerprint library and plan to bring the power of this platform to other diseases.